Lv64
1800 积分 2024-04-09 加入
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
27天前
已完结
Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study
30天前
已完结
Novel methodologies for clinical research in radiation oncology: Time to think outside of the box? A narrative review
4个月前
已关闭
Novel methodologies for clinical research in radiation oncology: Time to think outside of the box? A narrative review
4个月前
已完结
Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target
6个月前
已完结
Discovery of potent, orally active compounds of tyrosine kinase and Serine/threonine-protein kinase inhibitor with anti-tumor activity in preclinical assays
6个月前
已完结
Advanced Delivery Strategies of Nintedanib for Lung Disorders and Beyond: A Comprehensive Review
6个月前
已完结
Brief Report: Successful Pregnancy and Healthy Baby Outcome in a TKI-refractory ALK+ NSCLC Patient with CNS Metastasis Treated with Lorlatinib with Maternal-fetal Pharmacokinetics and Child Milestone Development Correlations
6个月前
已完结
Learning from the LEAP trial series: Optimizing clinical trial design for combination therapies
6个月前
已完结
Anlotinib versus placebo as adjuvant therapy for localized high-grade soft tissue sarcomas: a phase 2, double-blinded, randomized controlled trial
8个月前
已完结
皖公网安备34019202002308
